Casanova, M. J.Chaparro, M.Minguez, M.Ricart, E.Taxonera, C.Garcia-Lopez, S.Guardiola, J.Lopez-San Roman, A.Iglesias, E.Beltran, B.Sicilia, B.Vera, M. I.Hinojosa, J.Riestra, S.Domenech, E.Calvet, X.Perez-Calle, J. L.Martin-Arranz, M. D.Aldeguer, X.Rivero, M.Monfort, D.Barrio, J.Esteve, M.Marquez, L.Lorente, R.Garcia-Planella, E.de Castro, L.Bermejo, F.Merino, O.Rodriguez-Perez, A.Martinez-Montiel, P.Van Domselaar, M.Alcain, G.Dominguez-Cajal, M.Munoz, C.Gomollon, F.Fernandez-Salazar, L.Garcia-Sepulcre, M. F.Rodriguez-Lago, I.Gutierrez, A.Arguelles-Arias, F.Rodriguez, C.Rodriguez, G. E.Bujanda, L.Llao, J.Varela, P.Ramos, L.Huguet, J. M.Almela, P.Romero, P.Navarro-Llavat, M.Abad, A.Ramirez-de la Piscina, P.Lucendo, A. J.Sese, E.Madrigal, R. E.Charro, M.Garcia-Herola, A.Pajares, R.Khorrami, S.Gisbert, J. P.2025-01-072025-01-072019-03-011873-9946https://hdl.handle.net/10668/25929enEffectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registryconference outputopen access10.1093/ecco-jcc/jjy222.5631876-4479https://academic.oup.com/ecco-jcc/article-pdf/13/Supplement_1/S329/27600514/jjy222.563.pdf460544501290